News & Analysis on Clinical Trial Services & Contract Research And Development
The FDA has issued Eli Lilly with a warning letter detailing a significant deviation from cGMP at its API production facility in Puerto Rico, which makes ingredients used in Humalog (insulin lispro), a diabetes treatment.
The aging population is driving manufacturers to develop packaging that is easier to open, while still remaining child-resistant, but this can increase costs and affect sustainability, according to a director.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at PPD, LAB Research, Cedra and InVentiv Health.
NanoGuardian has licensed its NanoEncryption technology to Capsugel, a division of Pfizer, for use as an anti-counterfeiting system on the company’s capsule-based medications.
After a period of de-stocking in the first half of 2009, DSM’s nutrition business has weathered the economic slump well; pharma, too, picked up speed towards the end of the year.
In the economic downturn biotechs have cut back on outsourcing to Asia and opted to use the US instead because they lack the resources to manage overseas relationships, according to a SOCMA representative.
Parexel has opened a 40 bed early phase clinical trial unit in South Africa, increasing its Phase I capabilities in the country and adding to its patient recruitment focused SuperSites network.